Close X
Get more out of WDDTY.com
by joining the site for free
Free 17-point plan to great health
Twice weekly e-news bulletins
Access to our News, Forums and Blogs
Sign up for free and claim your
17-point plan to great health
Free 17-point plan to great health

Twice weekly e-news bulletins

Access to our News, Forums and Blogs
OR

If you want to read our in-depth research articles or
have our amazing magazine delivered to your home
each month, then you have to pay.


Click here if you're interested
Helping you make better health choices

In shops now or delivered to your home from only £3.50 an issue!

Subscribe!

News1996April › Stroke medicine: proves fatal › April 1996

Stroke medicine: proves fatal

Stroke victims given standard t-PA (human tissue plasminogen activator) treatment face a very high risk of suffering a brain hemorrhage, and possibly a fatal one

Stroke victims given standard t-PA (human tissue plasminogen activator) treatment face a very high risk of suffering a brain hemorrhage, and possibly a fatal one.

Research among 291 stroke patients found that 6.4 per cent of those given the treatment went on to suffer a hemorrhage, and half of those died. This compares with just 0.6 per cent who suffered a hemorrhage after being given a placebo treatment.

Another study, this time among 333 stroke patients, found little difference in recovery between those given standard treatment and those given a placebo.

The one positive outcome was that patients whose treatment was started within 90 minutes of the start of the stroke did better than those whose treatment was delayed.


You may also be interested in...

Latest Tweet

About

Since 1989, WDDTY has provided thousands of resources on how to beat asthma, arthritis, depression and many other chronic conditions.

Start by looking in our fully searchable database, active and friendly community forums and the latest health news.

Positive SSL Wildcard

Facebook Twitter

Most Popular Health Website of the Year 2014

© 2010 - 2017 WDDTY Publishing Ltd.
All Rights Reserved